CSE’s James Black recently spoke to Bruce Linton, Founder and former Chairman and CEO at Canopy Growth Corporation to reflect on his recent investment and advising activities in the technology, cannabis, and ‘neuro-pharmaceuticals’ sectors.
In this conversation Bruce explains how the pandemic is forcing us to rethink healthcare and how we need to leverage technology’s use in medicine (3:51), why he didn’t take time off after his departure from Canopy (8:30), and the two different paths that the US and Canadian cannabis markets are taking as the global market continues to develop (13:59).
Listen until the end to hear Bruce’s reflections on what it is like to work with Sir Terry Matthews, his interest in the neuro-pharmaceuticals space (aka “psychedelics”), and what he’s learned about leadership in tumultuous times.
Related Links
brucelinton.com
vireohealth.com
slangww.com